Exploratory immunogenicity outcomes of peanut oral immunotherapy: Findings from the PALISADE trial.

"CONFLICT OF INTEREST STATEMENT Caroline Nilsson: Grants to my institution and advisory board fees from Aimmune Therapeutics, a Nestlé Health Science company; lecture fees from ALK, GSK, MEDA, and Thermo Fisher; advisory board fees from Novartis. Andrea Vereda: Employee of Aimmune Therapeutics, a Nestlé Health Science company. Magnus P. Borres: Employee of Thermo Fisher Scientific. Mats Andersson: Employee of Thermo Fisher Scientific. Eva Södergren: Employee of Thermo Fisher Scientific. Magnus Rudengren: Employee of Thermo Fisher Scientific. Alex Smith: Former employee and shareholder of Aimmune Therapeutics, a Nestlé Health Science company. Reyna J. Simon: Former employee and shareholder of Aimmune Therapeutics, a Nestlé Health Science company. Robert Ryan: Employee of Aimmune Therapeutics, a Nestlé Health Science company. Montserrat Fernández‐Rivas: Grants to my institution, consulting fees, and payments or honoraria from Aimmune Therapeutics, a Nestlé Health Science company; consulting fees from Novartis, Reacta Healthcare, and SPRIM; payments or honoraria from ALK, Diater, Ediciones Mayo S.A., EPG Health, GSK, HAL Allergy, and Novartis; participation on a data safety monitoring board for DBV Technologies. Daniel Adelman: Former employee and shareholder of Aimmune Therapeutics, a Nestlé Health Science company. Brian P. Vickery: Grants to my institution from Aimmune Therapeutics, a Nestlé Health Science company, DBV Technologies, FARE, Genentech, NIH‐NIAID, and Regeneron; consulting fees from Aimmune Therapeutics, a Nestlé Health Science company, AllerGenis, Aravax, DBV Technologies, FARE, Reacta, and Regeneron. Former employee and former shareholder owner of Aimmune Therapeutics, a Nestlé Health Science company."

"The authors wish to acknowledge the ARC003 (PALISADE) Research Groups as well as the investigative center trial staff, the trial participants, and their families. This study was sponsored by Aimmune Therapeutics, a Nestlé Health Science company, and Thermo Fisher Scientific. Writing and editorial assistance was provided by Karyn Liu, PhD, and Cheryl Casterline, MA (Peloton Advantage, LLC, and OPEN Health company, Parsippany, NJ), and funded by Aimmune Therapeutics, a Nestlé Health Science company."

"Clinical Trial Registration ClinicalTrials.gov identifier: NCT02635776."